New cocktail of drugs could shrink stomach tumors before surgery

NCT ID NCT07069712

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests several new drug combinations given before and after surgery for stomach or esophageal cancer. About 100 people with resectable tumors will receive these treatments to see if they are safe and can shrink or eliminate the cancer. The goal is to improve outcomes by attacking the cancer more effectively before surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

AZD0901, Rilvegostomig, Trastuzumab Deruxtecan, Capecitabine, 5-Fluorouracil, FLOT chemotherapy

What this could lead to

If successful, this could lead to better treatment options before surgery for stomach cancer, potentially improving survival and reducing recurrence.

What could go wrong

This is an early-phase trial with only 100 participants, so results may not apply to everyone. The new drug combinations may cause side effects or not work better than current treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal adenocarcinoma gastric adenocarcinoma gastric neoplasm gastroesophageal adenocarcinoma gastroesophageal junction adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROESOPHAGEAL ADENOCARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Newark, Delaware, 19713, United States
Research Site
RECRUITING

Washington D.C., District of Columbia, 20007, United States
Research Site
RECRUITING

Fairway, Kansas, 66205, United States
Research Site
RECRUITING

North Shores, Michigan, 49444, United States
Research Site
NOT_YET_RECRUITING

New York, New York, 10032, United States
Research Site
RECRUITING

New York, New York, 10065, United States
Research Site
NOT_YET_RECRUITING

Pittsburgh, Pennsylvania, 15232, United States
Research Site
SUSPENDED

Toronto, Ontario, M5G 2M9, Canada
Research Site
RECRUITING

Montreal, Quebec, H2X 3E4, Canada
Research Site
RECRUITING

Montreal, Quebec, H4A 3J1, Canada
Research Site
RECRUITING

Beijing, 100142, China
Research Site
RECRUITING

Changchun, 130021, China
Research Site
RECRUITING

Changzhi, 046000, China
Research Site
RECRUITING

Chengdu, 610041, China
Research Site
RECRUITING

Chengdu, 610042, China
Research Site
NOT_YET_RECRUITING

Fuzhou, 350014, China
Research Site
RECRUITING

Hangzhou, 310003, China
Research Site
RECRUITING

Hangzhou, 310014, China
Research Site
RECRUITING

Kunming, 650118, China
Research Site
RECRUITING

Qingdao, 266003, China
Research Site
RECRUITING

Shanghai, 200025, China
Research Site
WITHDRAWN

Shijiazhuang, 050020, China
Research Site
RECRUITING

Tbilisi, 0112, Georgia
Research Site
RECRUITING

Tbilisi, 0114, Georgia
Research Site
RECRUITING

Tbilisi, 0144, Georgia
Research Site
RECRUITING

Tbilisi, 0159, Georgia
Research Site
RECRUITING

Florence, 50134, Italy
Research Site
RECRUITING

Milan, 20133, Italy
Research Site
RECRUITING

Milan, 20141, Italy
Research Site
RECRUITING

Milan, 20162, Italy
Research Site
WITHDRAWN

Modena, 41124, Italy
Research Site
RECRUITING

Pisa, 56100, Italy
Research Site
RECRUITING

Rozzano, 20089, Italy
Research Site
NOT_YET_RECRUITING

Udine, 33100, Italy
Research Site
RECRUITING

Vicenza, 36100, Italy
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
RECRUITING

Fukuoka, 812-8582, Japan
Research Site
RECRUITING

Hidaka-shi, 350-1298, Japan
Research Site
RECRUITING

Kashiwa, 277-8577, Japan
Research Site
RECRUITING

Kitaadachi-gun, 362-0806, Japan
Research Site
RECRUITING

Kōtoku, 135-8550, Japan
Research Site
RECRUITING

Nagoya, 464-8681, Japan
Research Site
RECRUITING

Osaka, 541-8567, Japan
Research Site
WITHDRAWN

Osaka, 558-8558, Japan
Research Site
RECRUITING

Suita-shi, 565-0871, Japan
Research Site
RECRUITING

Yokohama, 241-8515, Japan
Research Site
WITHDRAWN

Bialystok, 15-027, Poland
Research Site
WITHDRAWN

Warsaw, 02-034, Poland
Research Site
RECRUITING

Barcelona, 08035, Spain
Research Site
RECRUITING

Barcelona, 08036, Spain
Research Site
RECRUITING

Elche, 03203, Spain
Research Site
RECRUITING

Madrid, 28007, Spain
Research Site
RECRUITING

Málaga, 29010, Spain
Research Site
RECRUITING

Ourense, 32005, Spain
Research Site
RECRUITING

Oviedo, 33011, Spain
Research Site
RECRUITING

Santander, 39008, Spain
Research Site
RECRUITING

Valencia, 46010, Spain
Research Site
RECRUITING

Kaohsiung City, 80756, Taiwan
Research Site
RECRUITING

Tainan, 704, Taiwan
Research Site
RECRUITING

Taipei, 11217, Taiwan
Research Site
RECRUITING

Taoyuan, 33305, Taiwan
Research Site
WITHDRAWN

Adapazarı, 54100, Turkey (Türkiye)
Research Site
WITHDRAWN

Erzurum, 25240, Turkey (Türkiye)
Research Site
WITHDRAWN

Fatih-Istanbul, 34098, Turkey (Türkiye)
Research Site
WITHDRAWN

Istanbul, 34722, Turkey (Türkiye)
Research Site
WITHDRAWN

Bristol, BS2 8ED, United Kingdom
Research Site
RECRUITING

Dundee, DD1 9SY, United Kingdom
Research Site
RECRUITING

Headington, OX3 7LJ, United Kingdom
Research Site
NOT_YET_RECRUITING

London, E1 1BB, United Kingdom
Research Site
RECRUITING

Norwich, NR4 7UY, United Kingdom